Therapies targeting exogenous cholesterol uptake: new insights and controversies. - Wikidata - awgldk - TriplyDB

Therapies targeting exogenous cholesterol uptake: new insights and controversies.

Therapies targeting exogenous cholesterol uptake: new insights and controversies.

http://www.wikidata.org/entity/Q37824292

about

Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice Isoform-specific inhibitors of ACATs: recent advances and promising developments.Probiotics determine hypolipidemic and antioxidant effects in hyperlipidemic hamsters.

P2860

Q37118772-AA3D5638-6708-4F50-A6E9-755454A8779F Q37958067-3C6C23E1-C64B-4430-BBE8-EDE51058FE79 Q51751625-BC0CDFB2-2B50-4FFD-B08B-31B600392E8F

P2860

Therapies targeting exogenous cholesterol uptake: new insights and controversies.

http://www.wikidata.org/entity/Q37824292

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapies targeting exogenous cholesterol uptake: new insights and controversies.

@en

Therapies targeting exogenous cholesterol uptake: new insights and controversies.

@nl

type

label

Therapies targeting exogenous cholesterol uptake: new insights and controversies.

@en

Therapies targeting exogenous cholesterol uptake: new insights and controversies.

@nl

prefLabel

Therapies targeting exogenous cholesterol uptake: new insights and controversies.

@en

Therapies targeting exogenous cholesterol uptake: new insights and controversies.

@nl

P1433

Q37824292-CA8407E1-9143-40C4-8640-ED2FB404FDCE

P1476

Q37824292-6DE7248D-5473-4A9B-B85E-7F9AD2CA550A

P2093

Q37824292-54E14D72-E381-4327-BC4B-7B073DF24E84

P2860

Q37824292-138C3804-8307-4B6A-9FD7-8F44E3679BAB

Q37824292-15EACDA7-A666-4E03-922E-273987C5CC3B

Q37824292-218559F0-3C0D-4A6D-B099-488C3E52DB45

Q37824292-21A897E0-F969-4792-9FDE-C9E11421008C

Q37824292-22904FAF-2E41-487A-A5CD-1ECDC082866E

Q37824292-28730174-C7B2-4C77-8C71-51FA5EF75930

Q37824292-46FF402A-00E7-410B-BFAF-0AD96932C49D

Q37824292-4AC74A65-7B19-4147-ADEF-B2C0A149967C

Q37824292-5145FEA2-1628-47BA-9D25-7A8DD385236C

Q37824292-536284A3-B50F-4793-9B31-B96B585699C9

P2888

Q37824292-AF006F43-8BE4-4DDD-890A-C3B135FC6388

P304

Q37824292-A33965FE-EA88-41FE-B21C-4F62A391C3CC

P31

Q37824292-85a6ba9c-7cfb-40bf-a6b8-18d88c23a815

Q37824292-96C5AAB8-4FD7-4660-9341-AA4CBC75D03B

P356

Q37824292-D47D34F1-EF50-4340-80E5-7E8205F84DA0

P433

Q37824292-BFBC7E47-A539-4366-B68B-F17865EFB502

P478

Q37824292-512A2667-A1B6-44FC-972B-0275FD0E56B6

P577

Q37824292-175BE4ED-89A8-4245-B11B-1FEC1E6EE4FE

P698

Q37824292-27EAADA7-E337-4532-A18D-F1B68396DAE0

P356

S11883-010-0151-2

P1433

Current Atherosclerosis Reports

P1476

Therapies targeting exogenous cholesterol uptake: new insights and controversies.

@en

P2093

Michael H Davidson

http://www.w3.org/2001/XMLSchema#string

P2860

New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism

LXRS and FXR: the yin and yang of cholesterol and fat metabolism

Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo

Opposing Gatekeepers of Apical Sterol Transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-Binding Cassette Transporters G5 and G8 (ABCG5/ABCG8)

Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease.

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet

Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet.

Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.

P2888

s11883-010-0151-2

P304

95-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11883-010-0151-2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21188557

http://www.w3.org/2001/XMLSchema#string